Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Merz, Maximilian; Salwender, Hans; Haenel, Mathias et al.

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

HAEMATOLOGICA. Bd. 101. H. 12. 2016 S. E485-E487


Viardot, Andreas; Goebeler, Marie-Elisabeth; Hess, Georg et al.

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

BLOOD. Bd. 127. H. 11. 2016 S. 1410-1416


Schmidt, Cornelia S.; Lopez, Pamela Aranda; Dopheide, Joern F. et al.

Phenotypic and functional characterization of neutrophils and monocytes from patients with myelodysplastic syndrome by flow cytometry

CELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 19-26


Schiller, Ulrike; Inhestern, Johanna; Burger, Ulrike et al.

Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. Bd. 273. H. 10. 2016 S. 3337-3345




Bridgewater, J.; Lopes, A.; Wasan, H. et al.

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer

ANNALS OF ONCOLOGY. Bd. 27. H. 1. 2016 S. 134-140



Heimes, A. -S.; van de Sandt, L.; Edlund, K. et al.

Prognostic impact of interferon regulating factor 4 (IRF4) in node-negative breast cancer

ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 45-45


Almstedt, K.; Sicking, I.; Huangfu, S. et al.

Prognostic significance of focal adhesion kinase (FAK) in node-negative breast cancer (microarray based gene-expression- and immunohistochemistry-data)

ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 4-4